SCHEMBL4485225

SCHEMBL4485225

CN(c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccccc2)cc1)S(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.41
PDGFRB P09619 1/20 0.39
LMNA P02545 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CDK1 P06493 1/20 0.37
CDK2 P24941 1/20 0.37
CDK5 Q00535 1/20 0.37
CDC42BPA Q5VT25 1/20 0.37
SRPK1 Q96SB4 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 2/20 0.37
MAPK1 P28482 1/20 0.37
NR3C2 P08235 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485222 1.00 BACE1 (0.41) BACE1PDGFRBLMNAMEN1KMT2A
SCHEMBL4492066 0.89 RAB9A (0.41) BACE1PDGFRBLMNAMEN1KMT2A
SCHEMBL4492068 0.89 RAB9A (0.41) BACE1PDGFRBLMNAMEN1KMT2A
SCHEMBL4504955 0.89 MEN1 (0.43) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL4504950 0.89 MEN1 (0.43) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL4494110 0.88 PTGDR2 (0.36) BACE1LMNAMEN1KMT2AALDH1A1
SCHEMBL4494106 0.88 PTGDR2 (0.36) BACE1LMNAMEN1KMT2AALDH1A1
SCHEMBL6320388 0.88 ALDH1A1 (0.41) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL6320394 0.88 ALDH1A1 (0.41) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL4484962 0.87 BACE1 (0.38) BACE1PDGFRBLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885PDGFRB 105/4885LMNA 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.